Who Owns Syngenta?

Syngenta was formed in November 2000 when Novartis and AstraZeneca spun off and merged their agrochemical businesses, combining Novartis Agribusiness with Zeneca Agrochemicals. The merger created the world's largest crop protection company at the time, headquartered in Basel and listed in Zurich and New York.

The new company inherited deep pedigrees on both sides. Novartis itself came from the 1996 merger of Ciba-Geigy and Sandoz, Swiss chemical firms whose crop science work dated to the early twentieth century. Zeneca was the agrochemical arm of Britain's Imperial Chemical Industries. Together they gave Syngenta leading positions in herbicides, fungicides, insecticides, and seed care, plus a seeds business built from acquisitions like NK and Garst.

Through the 2000s Syngenta grew into a full-line seeds competitor, buying vegetable and field crop seed businesses and building a biotechnology pipeline for corn and soybean traits. It consistently ranked first or second globally in crop protection sales.

In 2015 and 2016 the company became the object of a bidding contest. Monsanto pursued it with offers exceeding $46 billion, which Syngenta's board rejected on antitrust and valuation grounds. ChemChina then agreed in February 2016 to buy Syngenta for $43 billion in cash, the largest overseas acquisition ever made by a Chinese company at that time. The deal closed in June 2017 and Syngenta was delisted.

In 2020 ChemChina merged Syngenta AG with ADAMA, the Israeli generic crop protection maker it had acquired in 2011, and Sinochem's agricultural units into Syngenta Group. When Sinochem Group and ChemChina merged into Sinochem Holdings in 2021, the group came under its current owner. A planned multi-billion-dollar Shanghai IPO was announced, approved in 2023, but later withdrawn amid weak equity markets, leaving the company state-owned as of late 2026.